Literature DB >> 20523983

PET assessment of disease activity in children with juvenile idiopathic arthritis.

Ukihide Tateishi1, Tomoyuki Imagawa, Noriko Kanezawa, Tetsuhiko Okabe, Kazuya Shizukuishi, Tomio Inoue, Shumpei Yokota.   

Abstract

BACKGROUND: The degree of 18-fluorodeoxyglucose (FDG) uptake is previously reported to correlate with physical examination and laboratory tests for evaluating disease activity in patients with rheumatoid arthritis. The clinical validity of (18)F-FDG positron emission tomography (PET) has not been evaluated in juvenile idiopathic arthritis (JIA).
OBJECTIVE: To assess the relationship between (18)F-FDG PET uptake and disease activity in children with JIA.
MATERIALS AND METHODS: A total of 560 joints in 28 children (mean age, 5.4 years; range, 1-16 years) with JIA who had undergone whole-body (18)F-FDG PET before treatment were retrospectively assessed clinically, biochemically and radiographically. PET images were assessed independently by two readers. We investigated the relationships between the degree of synovial (18)F-FDG uptake and radiographic and clinical symptoms and laboratory findings.
RESULTS: Joint tenderness and swelling had a positive association with abnormal (18)F-FDG uptake in the joint [odds ratio (OR) 5.37, 7.12, respectively]. The standardized uptake value (SUV) max correlated with the neutrophil count, plasma C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and matrix metalloproteinase (MMP) 3. Joint erosion (OR, 6.17), soft-tissue swelling (OR, 3.77), major joints involvement (OR, 3.50), tenderness (OR, 5.22), and CRP concentration in plasma (OR, 1.81) were positively associated with SUVmax.
CONCLUSION: The degree of (18)F-FDG uptake may be associated with the severity of synovitis in children with JIA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523983     DOI: 10.1007/s00247-010-1716-5

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  24 in total

Review 1.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

2.  Etanercept in systemic juvenile idiopathic arthritis.

Authors:  R A G Russo; M M Katsicas; M Zelazko
Journal:  Clin Exp Rheumatol       Date:  2002 Sep-Oct       Impact factor: 4.473

3.  Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

Authors:  Pierre Quartier; Pierre Taupin; Franck Bourdeaut; Irène Lemelle; Pascal Pillet; Michel Bost; Jean Sibilia; Isabelle Koné-Paut; Sylvie Gandon-Laloum; Marc LeBideau; Brigitte Bader-Meunier; Richard Mouy; Marianne Debré; Paul Landais; Anne-Marie Prieur
Journal:  Arthritis Rheum       Date:  2003-04

4.  Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.

Authors:  M M Katsicas; R A G Russo
Journal:  Clin Exp Rheumatol       Date:  2005 Jul-Aug       Impact factor: 4.473

5.  Preliminary definition of improvement in juvenile arthritis.

Authors:  E H Giannini; N Ruperto; A Ravelli; D J Lovell; D T Felson; A Martini
Journal:  Arthritis Rheum       Date:  1997-07

6.  F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.

Authors:  Gerhard W Goerres; Adrian Forster; Daniel Uebelhart; Burkhardt Seifert; Valerie Treyer; Beat Michel; Gustav K von Schulthess; Achim H Kaim
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

7.  Dynamic visualization of a joint-specific autoimmune response through positron emission tomography.

Authors:  Brian T Wipke; Zheng Wang; Joonyoung Kim; Timothy J McCarthy; Paul M Allen
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

8.  Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.

Authors:  Valeria Gerloni; Irene Pontikaki; Maurizio Gattinara; Francesca Desiati; Elide Lupi; Alfredomaria Lurati; Alessandra Salmaso; Flavio Fantini
Journal:  Arthritis Rheum       Date:  2005-02

9.  A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis.

Authors:  Thomas Klit Pedersen; Annelise Küseler; John Gelineck; Troels Herlin
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

10.  Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.

Authors:  Anne Roivainen; Riitta Parkkola; Timo Yli-Kerttula; Pertti Lehikoinen; Tapio Viljanen; Timo Möttönen; Pirjo Nuutila; Heikki Minn
Journal:  Arthritis Rheum       Date:  2003-11
View more
  2 in total

Review 1.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

2.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Authors:  Nehal N Mehta; YiDing Yu; Babak Saboury; Negar Foroughi; Parasuram Krishnamoorthy; Anna Raper; Amanda Baer; Jules Antigua; Abby S Van Voorhees; Drew A Torigian; Abass Alavi; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2011-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.